Status:
COMPLETED
Embryonic Ploidy Status in the Oncofertility Population
Lead Sponsor:
Reproductive Medicine Associates of New Jersey
Conditions:
Oncology
Fertility
Eligibility:
FEMALE
18-45 years
Brief Summary
looking at aneuploidy rates in embryos from patients who are going to or have undergone treatment for a malignancy with gonadotoxic treatment.
Detailed Description
The study involves oncofertility patients--individuals who are undergoing or have undergone therapy for a malignancy--who are interested in pursuing or preserving fertility. In particular, it investig...
Eligibility Criteria
Inclusion
- Present or past oncologic diagnosis requiring potentially gonadotoxic treatment
Exclusion
- Oocyte banking
- Use of oocyte donation
- Any contraindications to undergoing in vitro fertilization or gonadotropin stimulation
- Single gene disorder requiring more detailed embryo genetic analysis
Key Trial Info
Start Date :
December 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 21 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03350230
Start Date
December 1 2017
End Date
July 21 2022
Last Update
May 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Reproductive Medicine Associates of New Jersey
Basking Ridge, New Jersey, United States, 07920